Federal and state role in pharmacy compounding and reconstitution : exploring the right mix to protect patients : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, first session, on examining state and federal oversight to ensure the safety and quality of drug compounding--the process of mixing, combining, or altering ingredients to create a customized medication for an individual patient--by pharmacies, October 23, 2003.

FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2005

Distributed to some depository libraries in microfiche.Shipping list no.: 2005-0226-P."Printed for t...

State Medicaid drug formularies : cost saving measure or second-class medicine? : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Third Congress, first session, June 9, 1993.

United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee.

January 1995

Shipping list no.: 95-0030-P.Distributed to some depository libraries in microfiche.Includes bibliog...

A Primer on USP Chapter <797> “Pharmaceutical Compounding–Sterile Preparations, ” and USP Process for Drug and Practice Standards

David W. Newton
Lawrence A. Trissel

July 2015

In January 2004, Chapter <797> in the United States Pharmacopeia 27 became the first practice ...

Prescription Drugs: State and Federal Oversight of Drug Compounding by Pharmacies

United States. General Accounting Office.

October 2003

Testimony issued by the General Accounting Office with an abstract that begins "Drug compounding--th...

Improving and Enforcing Compounding Pharmacy Practices to Protect Patients

David A. Pegues

January 2006

Pharmaceutical compounding is the com-bining, mixing, or altering of ingredients to create a customi...

The Regulation of Pharmaceutical Compounding and the Determination of Need: Balancing Access and Autonomy with Patient Safety

Riley, Rebecca J.

June 2012

Pharmaceutical compounding, the creation and dispensing of custom-made medications, is the root of t...

Prescription drug abuse and diversion : the role of prescription drug monitoring programs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, second session, on examining drug abuse prevention issues, focusing on the role of prescription drug monitoring programs, and federal privacy standards for PMPS, September 23, 2004.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2005

Shipping list no.: 2005-0175-P.Distributed to some depository libraries in microfiche."Printed for t...

Regulation of Compounding by the Food and Drug Administration: A Tale of 2 Circuits

Williams, Karl

May 2010

Federal regulation of the traditional art of pharmacy practice compounding is an unsettled area of t...

Pharmacy Compounding after the Drug Quality and Security Act

Lietzan, Erika

April 2014

On November 27, 2013, President Obama signed into law the Drug Quality and Security Act ( DQSA ), wh...

Drug Compounding: Clear Authority and More Reliable Data Needed to Strengthen FDA Oversight

United States. Government Accountability Office.

July 2013

A letter report issued by the Government Accountability Office with an abstract that begins "The aut...

Importation of prescription drugs : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, second session, on examining prescription drug reimportation, focusing on efforts to reduce drug costs, patient safety concerns, recent state action, fraudulent and counterfeit drugs, an international comparison of rising prescription drug expenditures, and S. 2328, to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, May 20, 2004.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2005

Distributed to some depository libraries in microfiche.Shipping list no.: 2005-0202-P."Printed for t...

Third in series on medicare reform : laying the groundwork for a RX drug benefit : hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Seventh Congress, first session, March 27, 2001.

United States. Congress. House. Committee on Ways and Means. Subcommittee on Health.

January 2001

"Serial no. 107-7."Shipping list no.: 2002-0025-P.Distributed to some depository libraries in microf...

Pharmacy, Board of

The State Board of Pharmacy was created in 1891, and it regulates the pharmacy practice to ensure ...

Pharmaceutical marketplace reform : is competition the right prescription? : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Washington, DC, November 16, 1993.

United States. Congress. Senate. Special Committee on Aging.

January 1994

"Serial no. 103-15."Shipping list no.: 94-0071-P.Distributed to some depository libraries in microfi...

Integrating prescription drugs into Medicare : hearing before the Committee on Ways and Means, House of Representatives, One Hundred Seventh Congress, second session, April 17, 2002.

United States. Congress. House. Committee on Ways and Means.

January 2002

"Serial no. 107-65."Shipping list no.: 2002-0254-P.Distributed to some depository libraries in micro...

FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2005

Distributed to some depository libraries in microfiche.Shipping list no.: 2005-0226-P."Printed for t...

State Medicaid drug formularies : cost saving measure or second-class medicine? : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Third Congress, first session, June 9, 1993.

United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee.

January 1995

Shipping list no.: 95-0030-P.Distributed to some depository libraries in microfiche.Includes bibliog...

A Primer on USP Chapter <797> “Pharmaceutical Compounding–Sterile Preparations, ” and USP Process for Drug and Practice Standards

David W. Newton
Lawrence A. Trissel

July 2015

In January 2004, Chapter <797> in the United States Pharmacopeia 27 became the first practice ...

Prescription Drugs: State and Federal Oversight of Drug Compounding by Pharmacies

United States. General Accounting Office.

October 2003

Testimony issued by the General Accounting Office with an abstract that begins "Drug compounding--th...

Improving and Enforcing Compounding Pharmacy Practices to Protect Patients

David A. Pegues

January 2006

Pharmaceutical compounding is the com-bining, mixing, or altering of ingredients to create a customi...

The Regulation of Pharmaceutical Compounding and the Determination of Need: Balancing Access and Autonomy with Patient Safety

Riley, Rebecca J.

June 2012

Pharmaceutical compounding, the creation and dispensing of custom-made medications, is the root of t...

Prescription drug abuse and diversion : the role of prescription drug monitoring programs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, second session, on examining drug abuse prevention issues, focusing on the role of prescription drug monitoring programs, and federal privacy standards for PMPS, September 23, 2004.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2005

Shipping list no.: 2005-0175-P.Distributed to some depository libraries in microfiche."Printed for t...

Regulation of Compounding by the Food and Drug Administration: A Tale of 2 Circuits

Williams, Karl

May 2010

Federal regulation of the traditional art of pharmacy practice compounding is an unsettled area of t...

Pharmacy Compounding after the Drug Quality and Security Act

Lietzan, Erika

April 2014

On November 27, 2013, President Obama signed into law the Drug Quality and Security Act ( DQSA ), wh...

Drug Compounding: Clear Authority and More Reliable Data Needed to Strengthen FDA Oversight

United States. Government Accountability Office.

July 2013

A letter report issued by the Government Accountability Office with an abstract that begins "The aut...

Importation of prescription drugs : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, second session, on examining prescription drug reimportation, focusing on efforts to reduce drug costs, patient safety concerns, recent state action, fraudulent and counterfeit drugs, an international comparison of rising prescription drug expenditures, and S. 2328, to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, May 20, 2004.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2005

Distributed to some depository libraries in microfiche.Shipping list no.: 2005-0202-P."Printed for t...

Third in series on medicare reform : laying the groundwork for a RX drug benefit : hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Seventh Congress, first session, March 27, 2001.

United States. Congress. House. Committee on Ways and Means. Subcommittee on Health.

January 2001

"Serial no. 107-7."Shipping list no.: 2002-0025-P.Distributed to some depository libraries in microf...

Pharmacy, Board of

The State Board of Pharmacy was created in 1891, and it regulates the pharmacy practice to ensure ...

Pharmaceutical marketplace reform : is competition the right prescription? : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Washington, DC, November 16, 1993.

United States. Congress. Senate. Special Committee on Aging.

January 1994

"Serial no. 103-15."Shipping list no.: 94-0071-P.Distributed to some depository libraries in microfi...

Integrating prescription drugs into Medicare : hearing before the Committee on Ways and Means, House of Representatives, One Hundred Seventh Congress, second session, April 17, 2002.

United States. Congress. House. Committee on Ways and Means.

January 2002

"Serial no. 107-65."Shipping list no.: 2002-0254-P.Distributed to some depository libraries in micro...

FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005.

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

January 2005

Distributed to some depository libraries in microfiche.Shipping list no.: 2005-0226-P."Printed for t...

State Medicaid drug formularies : cost saving measure or second-class medicine? : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Third Congress, first session, June 9, 1993.

United States. Congress. House. Committee on Government Operations. Human Resources and Intergovernmental Relations Subcommittee.

January 1995

Shipping list no.: 95-0030-P.Distributed to some depository libraries in microfiche.Includes bibliog...

A Primer on USP Chapter <797> “Pharmaceutical Compounding–Sterile Preparations, ” and USP Process for Drug and Practice Standards

David W. Newton
Lawrence A. Trissel

July 2015

In January 2004, Chapter <797> in the United States Pharmacopeia 27 became the first practice ...

Abstract

Extracted data

Abstract

Extracted data

Topics

Related items

Topics

Related items